ETN-006

N/A

Report date: 2024/11/20 14:15:33
NME

Base Information

Drug NameETN-006
Drug Alias NameETN-006ETN006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor TEF-4 inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional enhancer factor TEF-4Transcriptional coactivator YAP1
Therapy Area/IndicationsSolid tumoursLiver NeoplasmsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEternity Bioscience IncEtern BioPharma (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEternity Bioscience IncEtern BioPharma (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLiver NeoplasmsCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A